Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer
Links shared publicly online about this topic.
- 490total visits
Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer
fda.gov —
View full resource at fda.gov
Tags: Diabetes Type 2 Medication, Diabetes Medication, Cancer, Bladder Cancer, Urinary System, FDA, Actos, Safety
Most Recently Shared on February 21, 2011 at 8:40 pm By:
Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer http://t.co/8p9B2IZ via @AddThis
FDA Drug Safety Communication: Updated drug labels for pioglitazone-containing medicines - Drugs.com MedNews
drugs.com — “This update provides a follow-up to the Drug Safety Communication Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer1” View full resource at drugs.com
Most Recently Shared on August 5, 2011 at 1:06 pm By:
Drugs and Devices OW OW Health
FDA Drug Safety Communication: Updated drug labels for pioglitazone-containing medicines: This update prov... http://bit.ly/pFG8cj #drug
FDA updates safety review of pioglitazone & risk of bladder cancer
newsroom.heart.org — “AHA Comment” View full resource at newsroom.heart.org
Most Recently Shared on June 17, 2011 at 3:04 pm By:
FDA updates ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer: American Heart A... http://bit.ly/iFWPhD
Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today
t.co — “Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing study. The warning comes just days after two Eu” View full resource at t.co
Most Recently Shared on June 16, 2011 at 4:41 pm By:
Medical News: FDA Warns of Bladder Cancer Risk With Actos~ http://t.co/94nRiwM.
Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today
medpagetoday.com — “Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing study. The warning comes just days after two Eu” View full resource at medpagetoday.com
Most Recently Shared on June 16, 2011 at 2:50 pm By:
The Kidney Group Physician Group and Nephrology
FDA warns of bladder cancer risk with Actos. #diabetes http://t.co/Gz7EeII
Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today
medpagetoday.com — “Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing study. The warning comes just days after two Eu” View full resource at medpagetoday.com
Most Recently Shared on June 15, 2011 at 10:12 pm By:
Days after France & Germany ban Actos because of bladder cancer risk, FDA issues warning (via @health_tweets) http://dld.bz/ad38X #diabetes
Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today
medpagetoday.com — “Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing study. The warning comes just days after two Eu” View full resource at medpagetoday.com
Most Recently Shared on June 15, 2011 at 9:51 pm By:
FDA Warns of Bladder Cancer Risk With Actos http://bit.ly/ihL6bo
Advertisement
